Deletion of Gadd45a Expression in Mice Leads to Cognitive and Synaptic Impairment Associated with Alzheimer’s Disease Hallmarks.
| dc.contributor.author | Griñán Ferré, Christian | |
| dc.contributor.author | Jarne Ferrer, Júlia | |
| dc.contributor.author | Bellver Sanchis, Aina | |
| dc.contributor.author | Ribalta Vilella, Marta | |
| dc.contributor.author | Barroso Fernández, Emma | |
| dc.contributor.author | Salvador, Jesús M. | |
| dc.contributor.author | Jurado Aguilar, Javier | |
| dc.contributor.author | Palomer Tarridas, Francesc Xavier | |
| dc.contributor.author | Vázquez Carrera, Manuel | |
| dc.contributor.author | Pallàs i Llibería, Mercè, 1964- | |
| dc.date.accessioned | 2024-04-16T07:38:42Z | |
| dc.date.available | 2024-04-16T07:38:42Z | |
| dc.date.issued | 2024-02-23 | |
| dc.date.updated | 2024-04-16T07:38:47Z | |
| dc.description.abstract | <p><em>Gadd45 genes have been implicated in survival mechanisms, including apoptosis, autophagy,</em></p><p><em>cell cycle arrest, and DNA repair, which are processes related to aging and life span. Here, we</em></p><p><em>analyzed if the deletion of Gadd45a activates pathways involved in neurodegenerative disorders such</em></p><p><em>as Alzheimer’s Disease (AD). This study used wild-type (WT) and Gadd45a knockout (Gadd45a−/−)</em></p><p><em>mice to evaluate AD progression. Behavioral tests showed that Gadd45a−/− mice presented lower</em></p><p><em>working and spatial memory, pointing out an apparent cognitive impairment compared with WT</em></p><p><em>animals, accompanied by an increase in Tau hyperphosphorylation and the levels of kinases involved</em></p><p><em>in its phosphorylation in the hippocampus. Moreover, Gadd45a−/− animals significantly increased the</em></p><p><em>brain’s pro-inflammatory cytokines and modified autophagy markers. Notably, neurotrophins and</em></p><p><em>the dendritic spine length of the neurons were reduced in Gadd45a−/− mice, which could contribute</em></p><p><em>to the cognitive alterations observed in these animals. Overall, these findings demonstrate that the</em></p><p><em>lack of the Gadd45a gene activates several pathways that exacerbate AD pathology, suggesting that</em></p><p><em>promoting this protein’s expression or function might be a promising therapeutic strategy to slow</em></p><p><em>down AD progression.</em></p> | |
| dc.format.extent | 1 p. | |
| dc.format.mimetype | application/pdf | |
| dc.identifier.idgrec | 747771 | |
| dc.identifier.issn | 1661-6596 | |
| dc.identifier.uri | https://hdl.handle.net/2445/210000 | |
| dc.language.iso | eng | |
| dc.publisher | MDPI | |
| dc.relation.isformatof | Reproducció del document publicat a: | |
| dc.relation.ispartof | International Journal of Molecular Sciences, 2024 | |
| dc.rights | cc-by (c) Griñán-Ferré C et al., 2024 | |
| dc.rights.accessRights | info:eu-repo/semantics/openAccess | |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
| dc.source | Articles publicats en revistes (Farmacologia, Toxicologia i Química Terapèutica) | |
| dc.subject.classification | Malaltia d'Alzheimer | |
| dc.subject.classification | Malalties neurodegeneratives | |
| dc.subject.classification | Epigenètica | |
| dc.subject.other | Alzheimer's disease | |
| dc.subject.other | Neurodegenerative Diseases | |
| dc.subject.other | Epigenetics | |
| dc.title | Deletion of Gadd45a Expression in Mice Leads to Cognitive and Synaptic Impairment Associated with Alzheimer’s Disease Hallmarks. | |
| dc.type | info:eu-repo/semantics/article | |
| dc.type | info:eu-repo/semantics/publishedVersion |
Fitxers
Paquet original
1 - 1 de 1